| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rheumatology 2001; 40: 267-273
© 2001 British Society for Rheumatology
Glucocorticoid-mediated repression of inflammatory cytokine production in fibroblast-like rheumatoid synoviocytes is independent of nuclear factor-
B activation induced by tumour necrosis factor
Department of Orthopaedic Surgery, College of Medicine, The Catholic University of Korea, Seoul and
1 Genetic Resources Center, Korea Research Institute of Bioscience and Biotechnology, Yusong, Taejon, Korea
Objective. To determine whether steroids inhibit the production of inflammatory cytokines by the inhibition of nuclear factor
B (NF-
B) activation in fibroblast-like rheumatoid synoviocytes (FLSs) under inflammatory conditions, and to determine whether steroids stimulate the induction of synthesis of the inhibitory protein I
B-
in the anti-inflammatory immune response of these cells.
Methods. Expression of the interleukin-6 (IL-6) and interleukin-1ß (IL-1ß) genes was measured by semi-quantitative reverse transcriptionpolymerase chain reaction (RT-PCR), and the secreted IL-6 was measured with the enzyme-linked immunosorbent assay. Inhibition of the NF-
B activation was examined with the electrophoretic mobility shift assay (EMSA). In order to study dexamethasone (DEX)-dependent regulation of I
B-
expression, we performed Western blotting before and after stimulation with tumour necrosis factor
(TNF-
).
Results. The inflammatory cytokine study showed that DEX suppressed gene expression and the production of protein in FLSs. EMSA demonstrated that identical amounts of NF-
B were present in the nucleus of the FLSs stimulated by TNF-
, with or without pretreatment with DEX. Treatment of FLSs with DEX did not induce an increase in I
B-
sufficient to prevent nuclear translocation of NF-
B on stimulation with TNF-
.
Conclusion. DEX may suppress the production of inflammatory cytokines, such as IL-6 and IL-1ß, but it neither prevents the translocation of NF-
B to the nucleus nor induces the synthesis of I
B-
protein in FLSs stimulated by TNF-
.
KEY WORDS: Dexamethasone, Rheumatoid arthritis, Synoviocytes, NF-
B, I
B-
, TNF-
, IL-6, IL-1ß.
Correspondence to: G. T. Oh, Genetic Resources Center, Korea Research Institute of Bioscience and Biotechnology, P. O. Box 115, Yusong, Taejon 305600, Korea
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. G. Bernier, D. D. Lazarus, E. Clark, B. Doyle, M. T. Labenski, C. D. Thompson, W. F. Westlin, and G. Hannig A methionine aminopeptidase-2 inhibitor, PPI-2458, for the treatment of rheumatoid arthritis PNAS, July 20, 2004; 101(29): 10768 - 10773. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-K. Park, W. S. Yang, N. J. Han, S. K. Lee, H. Ahn, I. K. Lee, J. Y. Park, K.-U. Lee, and J. D. Lee Dexamethasone regulates AP-1 to repress TNF-{alpha} induced MCP-1 production in human glomerular endothelial cells Nephrol. Dial. Transplant., February 1, 2004; 19(2): 312 - 319. [Abstract] [Full Text] [PDF] |
||||

